Umesalma and sudhandiran found that ellagic acid prevented the development of CRC in rats induced by the chemical carcinogen 1,2dimethylhydrazine by targeting the NF-κB/COX-2 pathway 165. The gene discussed is NFKB1; the disease is colorectal carcinoma.